The Impact of Changes in Regulation, Demographics and Consumer Trends

The Dietary Supplements Market Outlook: The Impact of Changes in Regulation, Demographics and Consumer Trends

LYON, France — announces that a new market research report related to the worldwide healthcare industry is available in its catalogue.

The Dietary Supplements Market Outlook: The impact of changes in regulation, demographics and consumer trends

To order that report:

For more information, contact Nicolas by email , or by phone +33 4 37 65 17 03.


The dietary supplement market is facing a difficult time with significant shifts in consumer demographics, extensive negative media coverage and legislative changes.

In Europe the recent adoption of health claim harmonization via Articles 13 and 14 will significantly impact the ability to market products throughout the region.

In the US the recent release of final GMP and AER regulations and a new FDA unit relating to food safety will potentially affect trade both internally and externally.

This new management report analyzes key regulative, demographic and product development changes in the dietary supplements market.

The report also details the results of our proprietary industry survey, industry in-depth interviews and case study analysis including GSK’s MyAlli.

Table of content

Executive Summary


Market drivers and issues

The supplements market

Innovation and NPD

Key and future trends in supplements

Industry survey


Chapter 1 Introduction



Research methodology

What is this report about?

The supplements market defined

Vitamins and minerals

Herbs and botanicals

Sports and specialty

Chapter 2 Market drivers and issues



Factors affecting the growth of the industry


Cost of healthcare

Exchange rates

Demographics and beyond…

Regulatory issues – opportunities and threats for manufacturers

United States



Chapter 3 The supplements market



Sales of supplements

United States

Vitamin and mineral markets

Herbal and botanical markets

Sports and specialty


Overview of European markets

Vitamin and mineral markets

Herbal and botanicals

Sports and specialty

Industry interview – High5


Vitamins and minerals

Herbals and botanicals

Sports and specialty

Chapter 4 Innovation and NPD



Innovation and NPD

Category analysis

Vitamins and minerals

Vitamin B6 – the next folic acid?

Vitamin C and the common cold

Vitamin D – upping intake

Vitamin D and metabolic syndrome

Vitamin K the cardioprotectant

Herbs and botanicals

EGCG – Teavigo’s seal of guarantee

Botanical fingerprinting and GMP

American ginseng

Industry interview – Aloecorp

Sports and specialty

Age still a big driver

Whey gets blocked in China…A sign of things to come?

Case study – MyAlli

Regional analysis

United States

Obesity still BIG business


Health claims in the US….Is the EFSA influencing the US?

Industry interview – insight into North America


Innovation stifled by regulation

Nanotechnology – big things come in small packages

Industry interview – insight into Europe


Economic recovery has not guaranteed success for supplement market

Innovation in the hands of weight loss and beauty

Soy peptide gets a brake

Industry insight – insight into Asia

Chapter 5 Key and future trends in supplements




Demographic differentiation

Chapter 6 Industry survey



Supplements NPD

Target audience

Price premiums

Regional potential

Distribution channels

Supplement categories

Supplements versus food and drinks

Impact of external factors on supplement NPD

Launching a dietary supplement

Marketing supplements

Chapter 7 Conclusions



Growth opportunities and resistances


Delivery systems

Disease prevention and healthcare (self-medication)

Development of emerging markets

EU and US regulations


Purity and ingredient efficacy

Partnerships: making traditional and local insights work

The rise of Rx-to-OTC

Chapter 8 Appendix



List of Figures

Figure 2.1: Regulatory structure in Europe

Figure 2.2: Food for Special Dietary Uses (FOSDU)

Figure 2.3: Food for Specific Health Uses (FOSHU)

Figure 2.4: Overview of Japanese regulatory system of dietary supplements

Figure 3.5: Coral Calcium Supreme

Figure 3.6: Pfizer’s Zoloft

Figure 3.7: Phosphagen Elite from EAS containing Carnosyn beta-alanine

Figure 3.8: Advantra-Z (Citrus aurantium) from Nutratech

Figure 3.9: Maximuscle products

Figure 3.10: Super Carbs from High-5

Figure 4.11: Percentage share of supplements launched, by category 2004 and 2007

Figure 4.12: Percentage growth of supplements launched, 2004 and 2007

Figure 4.13: DSM Nutritionals Teavigo seal of quality

Figure 4.14: Wisconsin Ginseng Board seal

Figure 4.15: MyAlli starter pack

Figure 4.16: MyAlli starter pack with Steven Burton, Vice President of the weight control unit

Figure 4.17: Cross channel growth in healthcare products GSK

Figure 4.18: Percentage share of supplements launched, by region, 2004 and 2007

Figure 4.19: Percentage share of supplements in each region, by category, 2007

Figure 4.20: Nutri-Nano CoQ10 from Solgar, US

Figure 5.21: Cold-Fx from CV Technologies Inc

Figure 5.22: AC-11(R) from Optigenex Inc

Figure 5.23: Acomplia from Sanofi-Aventis

Figure 5.24: Drivers of dietary change

Figure 5.25: Influence of a negative meta-analysis on Avandia

Figure 6.26: The importance of key health areas in supplements NPD over the next 5 years

Figure 6.27: Demographic groups that will be the most important for the growth of the supplements market over the next 5 years

Figure 6.28: Price premium consumers are willing to pay for a particular benefit

Figure 6.29: Regional growth potential for supplements manufacturers over the next 5 years

Figure 6.30: Sales growth potential in key distribution channels over the next 5 years

Figure 6.31: Supplements categories that will offer the most sales growth potential over the next 5 years

Figure 6.32: Future sales growth – from supplements or from use in food and drinks

Figure 6.33: Impact key factors will have on supplements NPD over the next 5 years

Figure 6.34: The importance of key factors for a successful launch of a dietary supplement

Figure 6.35: The importance of various forms of marketing for the launch of dietary supplements

Figure 7.36: Clarinol, Teavigo and Ocean Nutrition MEG-3

List of Tables

Table 3.1: Sales of dietary supplements in the US, $m, 2002-2006

Table 3.2: Per capita sales of dietary supplements in the US, $, 2002-2006

Table 3.3: Sales of dietary supplements in Europe, $m, 2002-2006

Table 3.4: Per capita sales of supplements, $, Europe, 2002-2006

Table 3.5: Sales of dietary supplements in Japan, $m, 2002-2006

Table 3.6: Per capita sales of supplements, $, Japan, 2002-2006

More market research reports? Go to

COPYRIGHT 2007 Business Wire

COPYRIGHT 2008 Gale, Cengage Learning